Stockscreener 앱 받기
1.12
0.90%
0.01
시간 외 거래:
1.15
0.03
+2.68%
전일 마감가:
$1.11
열려 있는:
$1.14
하루 거래량:
356.88K
Relative Volume:
0.52
시가총액:
$94.77M
수익:
-
순이익/손실:
$-93.61M
주가수익비율:
-0.5308
EPS:
-2.11
순현금흐름:
$-71.16M
1주 성능:
+13.23%
1개월 성능:
-6.67%
6개월 성능:
-16.42%
1년 성능:
-8.20%
1일 변동 폭
$1.07
$1.16
1주일 범위
$0.9676
$1.2199
52주 변동 폭
$0.8319
$2.11
Immunic Inc Stock (IMUX) Company Profile
명칭
Immunic Inc
전화
(332) 255-9818
주소
1200 AVENUE OF THE AMERICAS, NEW YORK
IMUX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
1.12 | 94.77M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 개시 | William Blair | Outperform |
| 2024-11-25 | 개시 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-27 | 개시 | B. Riley Securities | Buy |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2021-04-15 | 개시 | Aegis Capital | Buy |
| 2021-03-24 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-02 | 개시 | SVB Leerink | Outperform |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-08-07 | 재개 | ROTH Capital | Buy |
| 2020-07-20 | 개시 | BMO Capital Markets | Outperform |
| 2020-06-05 | 개시 | Wedbush | Outperform |
| 2020-05-11 | 개시 | H.C. Wainwright | Buy |
| 2020-03-25 | 개시 | ROTH Capital | Buy |
| 2019-07-11 | 개시 | Chardan Capital Markets | Buy |
모두보기
Immunic Inc 주식(IMUX)의 최신 뉴스
Immunic: A Strong Buy With Imminent Data Readout That Should Send Shares Higher (NASDAQ:IMUX) - Seeking Alpha
Immunic Inc (IMUX) Offers An Excellent Investment Opportunity At Current Levels - Stocksregister
One Immunic Insider Raised Their Stake In The Previous Year - Yahoo Finance
Trading Day Review: Immunic Inc (IMUX) Gains Momentum, Closing at 1.14 - DWinneX
Brokerages Set Immunic, Inc. (NASDAQ:IMUX) Price Target at $13.20 - Defense World
IMUX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Immunic Inc (IMUX) stock on the rise: An overview - uspostnews.com
Immunic’s (IMUX) Buy Rating Reiterated at HC Wainwright - Defense World
HC Wainwright Has Optimistic View of Immunic FY2025 Earnings - Defense World
HC Wainwright Estimates Immunic’s Q1 Earnings (NASDAQ:IMUX) - Defense World
Immunic, Inc. (NASDAQ:IMUX) Is Expected To Breakeven In The Near Future - simplywall.st
Immunic Stock Price, Quotes and Forecasts | NASDAQ:IMUX - Benzinga
Immunic, Inc. Announces Closing of $5.1 Million Registered Direc - GuruFocus
Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode - MSN
Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - The Malaysian Reserve
Immunic Closes of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - citybiz
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - Eastern Progress
Immunic Raises $5.1 Million From Direct Stock Offering - marketscreener.com
Immunic Lands Strategic $5.1M Financing Deal: Aberdeen Investments Takes Lead Position - Stock Titan
Immunic closes $5.1M placement - Proactive Investors
Immunic announces pricing of $5.1M registered direct offering - MSN
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direc - GuruFocus
Immunic Announces $5.1 Million Securities Purchase Agreement - MSN
Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments | IMUX Stock News - GuruFocus
Immunic sets $5.1 million stock offering price By Investing.com - Investing.com Canada
Immunic sets $5.1 million stock offering price - Investing.com Australia
Immunic announces pricing of $5.1M direct offering to support clinical pipeline - Proactive financial news
Immunic Announces Pricing Of $5.1 Million Registered Direct Offering - marketscreener.com
Immunic Lands $5.1M Institutional Backing: Aberdeen Investments Takes Major Stake - Stock Titan
Critical Survey: Immunic (NASDAQ:IMUX) vs. Quoin Pharmaceuticals (NASDAQ:QNRX) - Defense World
What is Leerink Partnrs’ Estimate for Immunic Q1 Earnings? - Defense World
Immunic (NASDAQ:IMUX) Earns “Buy” Rating from D. Boral Capital - The AM Reporter
Immunic (NASDAQ:IMUX) Given “Buy” Rating at D. Boral Capital - Defense World
Immunic to present at AAN 2025 and German Biotech Days in April - Proactive financial news
Immunic, Inc. to Participate in Scientific and Industry Conferences in April - The Malaysian Reserve
IMMUNIC, INC. SEC 10-K Report - TradingView
Immunic CMO discusses significance of MS Awareness Month; progress with treatment - Proactive financial news
Immunic, Inc. (NASDAQ:IMUX) Receives $12.67 Average PT from Brokerages - Defense World
Immunic Inc. (IMUX) reports earnings - qz.com
Immunic Therapeutics: Interview With CEO Dr. Daniel Vitt About The Inflammatory And Autoimmune Diseases Therapy Company - Pulse 2.0
180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World
Immunic (NASDAQ:IMUX) Now Covered by Analysts at William Blair - Defense World
Immunic (NASDAQ:IMUX) Now Covered by William Blair - The AM Reporter
William Blair Initiates Coverage of Immunic (IMUX) with Outperform Recommendation - Nasdaq
William Blair sees Immunic stock outperforming on RMS therapy By Investing.com - Investing.com Australia
How did Immunic Inc (IMUX) fare last session? - uspostnews.com
William Blair sees Immunic stock outperforming on RMS therapy - Investing.com
Immunic Inc (IMUX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.19%
자본화:
|
볼륨(24시간):